FdaApplication
ANDA 215617
Identifiers
- fda_app_no: ANDA215617
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2025-02-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PHENYLEPHRINE HYDROCHLORIDE | PHENYLEPHRINE HYDROCHLORIDE | 0.5MG/5ML (0.1MG/ML) | SOLUTION;INTRAVENOUS |
1 product